Brief: Titan Pharmaceuticals Announces Pricing Of $9.7 Mln Registered Direct Offering
15/01/2021 14:29
Jan 15 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ANNOUNCES PRICING OF $9.7 MILLION
REGISTERED DIRECT OFFERING
* TITAN PHARMACEUTICALS - COMBINED PURCHASE PRICE FOR ONE
SHARE OF
COMMON STOCK AND EACH WARRANT WILL BE $3.55.
Source text for Eikon: ID:nPn2l3J5Xa
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.